GSK announces new commitment to improve access to vaccines with 5-year price freeze for countries graduating from GAVI Alliance support

May 20, 2014 GSK announced today that it will freeze the prices of its vaccines for five years for developing countries that graduate from GAVI Alliance support. By committing to offer GAVI Alliance prices for vaccines against pneumococcal disease, rotavirus and cervical cancer, GSK will support developing country governments as they transition to financing the full cost of their local …